TipRanks
Ocular Therapeutix (CH:0OT)
:0OT
Switzerland Market
0OT
Ocular Therapeutix
RESEARCH TOOLSreports

Ocular Therapeutix (0OT) Stock News & Sentiment

0 Followers
OCUL, IDXX, BIIB, BFLY, TMUS Trending With Analysts
Premium
Weekend Updates
OCUL, IDXX, BIIB, BFLY, TMUS Trending With Analysts
15d ago
BFLY
BIIB
Ocular Therapeutix Chief Strategy Officer Resigns for New Role
Premium
Company Announcements
Ocular Therapeutix Chief Strategy Officer Resigns for New Role
15d ago
8K
OCUL
Analyst Maintains Buy Rating on Axpaxli with $14 Price Target, Citing Large Retinal Market Opportunity and Manageable Regulatory Risk
Premium
Ratings
Analyst Maintains Buy Rating on Axpaxli with $14 Price Target, Citing Large Retinal Market Opportunity and Manageable Regulatory Risk
20d ago
OCUL
Ocular Therapeutix: Buy Rating Reiterated as Axpaxli’s Best-in-Class Durability Supports Valuation; $18 Price Target Maintained
Premium
Ratings
Ocular Therapeutix: Buy Rating Reiterated as Axpaxli’s Best-in-Class Durability Supports Valuation; $18 Price Target Maintained
1M ago
OCUL
Analyst Initiates Buy on Ocular Therapeutix, Citing Strong Ophthalmology Pipeline and Attractive Long-Term Valuation
Premium
Ratings
Analyst Initiates Buy on Ocular Therapeutix, Citing Strong Ophthalmology Pipeline and Attractive Long-Term Valuation
1M ago
OCUL
3 Best Stocks With 150%+ Upside to Buy This Week, According to Analysts
Premium
Market News
3 Best Stocks With 150%+ Upside to Buy This Week, According to Analysts
1M ago
OCUL
ONDS
Ocular Therapeutix: Buy Rating Reiterated on AXPAXLI Regulatory Progress and Durability Profile; Price Target Maintained at $25
Premium
Ratings
Ocular Therapeutix: Buy Rating Reiterated on AXPAXLI Regulatory Progress and Durability Profile; Price Target Maintained at $25
2M ago
OCUL
More CH:0OT News >

0OT News on the Web

Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), Palvella Therapeutics (PVLA)
TipRanks News
Bullish
Ocular Therapeutix initiated with a Buy at UBS
TipRanks News
Bullish
Analysts Call Ocular Selloff Overdone As Shares Bounce
TipRanks News
Neutral
Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst?
Insider Monkey
Neutral
Axpaxli’s Long-Acting Edge and Regulatory Momentum Support Unchanged $27 Price Target and Buy Rating
TipRanks News
Bullish
Ocular Therapeutix Crumbles As Profit-Takers Flee Rally
TipRanks News
Neutral
Ocular Therapeutix Tumbles As Rally Unravels And Risks Loom
TipRanks News
Neutral
Ocular Therapeutix Soars On Drug Milestone And Big Buyer
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average4 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is CH:0OT’s Media Buzz Sentiment?
Currently, no data Available
What is CH:0OT’s weekly average amount of articles?
In an average week, 4 articles about CH:0OT are published.
    What is CH:0OT’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    GKOSGlaukos
    CNCCentene
    ASNDAscendis Pharma
    GILDGilead Sciences
    MRKMerck & Company
    Showing the stocks with the most bullish news sentiment over the past week